By Kelly Cloonan
Emergent BioSolutions signed an agreement worth around $65 million to supply the Ontario Ministry of Health with Narcan nasal spray.
The contract will last a maximum of three years and supports the ministry's Ontario Naloxone Program, Emergent said Thursday.
The program will distribute Emergent's Narcan nasal spray, which aims to reverse the effects of an opioid poisoning in minutes, across Ontario to individuals at risk of opioid overdose and their friends and family through public health units, outreach programs, hospital emergency departments and urgent care, among other organizations.
Emergent has worked with the Ontario Ministry of Health to provide access to the spray across the province since 2018, the company said.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
May 01, 2025 18:29 ET (22:29 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.